Skip to main content
. Author manuscript; available in PMC: 2014 Nov 14.
Published in final edited form as: J Med Chem. 2013 Oct 29;56(21):10.1021/jm401290y. doi: 10.1021/jm401290y

TABLE 2.

Stimulation/Inhibition of [35S]GTPγS Binding Mediated by the MOR and KOR.

Compound MOR
KOR
Emax (%) EC50 (nM) Imax (%) IC50 (nM) Emax (%) EC50 (nM) Imax (%) IC50 (nM)
1ab 45 ± 4 73 ± 5 NI NA 80 ± 6 2.4 ± 0.6 NI NA
1bc 40 ± 0.87 47 ±9.0 NI NA 82 ± 10 14 ± 3.1 NI NA
1cc 83 ± 2.5 29 ± 4.6 NI NA 190 ± 6.4 22 ± 5.1 NI NA
7d 24 ± 0.90 39 ±7.8 69 ± 2.4 640 ± 76 140 ± 4.9 49 ± 1.3 NI NA
8d 34± 2.3 0.41 ± 0.021 64 ± 3.6 3.0 ± 0.56 59 ± 2.5 0.61 ± 0.049 49 ± 3.7 1.8 ± 0.20
9 34 ± 2.6 0.52 ± 0.086 70 ± 2.1 1.8 ± 0.38 72 ± 4.2 3.3 ± 0.27 44 ± 0.25 12 ± 1.4
10 47 ± 3.6 80 ± 13 60 ±0.55 500 ± 58 120 ± 2.4 140 ± 6.7 NI NA
11 28 ± 1.7 51 ± 6.6 76 ± 0.68 650 ± 100 140 ± 5.8 97 ± 6.9 NI NA
12 25 ± 1.7 0.52 ±0.076 76 ± 2.3 2.5 ± 0.26 85 ± 10.0 1.3 ± 0.10 27 ± 2.7 2.8 ± 0.42
a

Membranes from CHO cells that stably expressed the human MOR were incubated with varying concentrations of the compounds in the presence of 0.08 nM [35S]GTPγS. Data are the mean values ± SEMs from three experiments, performed in triplicate. NI= No Inhibition NA=Not Applicable.

b

Ref. 18.

c

Ref. 19.